Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Inventory (2022 - 2025)

Historic Change in Inventory for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$8737.0.

  • bioAffinity Technologies' Change in Inventory fell 9834.28% to -$8737.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9871.0, marking a year-over-year decrease of 3613.07%. This contributed to the annual value of $9124.0 for FY2024, which is 2951.17% down from last year.
  • Per bioAffinity Technologies' latest filing, its Change in Inventory stood at -$8737.0 for Q3 2025, which was down 9834.28% from $5189.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Change in Inventory registered a high of $20281.0 during Q2 2024, and its lowest value of -$8997.0 during Q1 2024.
  • Over the past 4 years, bioAffinity Technologies' median Change in Inventory value was $58.0 (recorded in 2022), while the average stood at $2348.9.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 500057.14% in 2023, then plummeted by 218238.34% in 2024.
  • bioAffinity Technologies' Change in Inventory (Quarter) stood at -$175.0 in 2022, then surged by 5000.57% to $8576.0 in 2023, then plummeted by 73.82% to $2245.0 in 2024, then crashed by 489.18% to -$8737.0 in 2025.
  • Its last three reported values are -$8737.0 in Q3 2025, $5189.0 for Q2 2025, and $11174.0 during Q1 2025.